Clinical Trial Update: Treatment With Ribavirin for Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ribavirin for metastatic breast cancer was terminated, with no published results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Jewish General Hospital | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED